<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>797</ReferenceId>
        <DateLastUpdated>2020-10-11-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12716894</PubmedId>
            <Abstract>Septic shock due to infections with Gram-negative bacteria is a severe disease with a high mortality rate. We report the identification of the antigenic determinants of an epitope that is present in enterobacterial lipopolysaccharide (LPS) and recognized by a cross-reactive monoclonal antibody (mAb WN1 222-5) regarded as a potential means of treatment. Using whole LPS and a panel of neoglycoconjugates containing purified LPS oligosaccharides obtained from Escherichia coli core types R1, R2, R3, and R4, Salmonella enterica, and the mutant strain E. coli J-5, we showed that mAb WN1 222-5 binds to the distal part of the inner core region and recognizes the structural element R1-alpha-d-Glcp-(1--&gt;3)-[l-alpha-d-Hepp-(1--&gt;7)]-l-alpha-d-Hepp 4P-(1--&gt;3)-R2 (where R1 represents additional sugars of the outer core and R2 represents additional sugars of the inner core), which is common to LPS from all E. coli, Salmonella, and Shigella. WN1 222-5 binds poorly to molecules that lack the side chain heptose or lack phosphate at the branched heptose. Also molecules that are substituted with GlcpN at the side chain heptose are poorly bound. Thus, the side chain heptose and the 4-phosphate on the branched heptose are main determinants of the epitope. We have determined the binding kinetics and affinities (KD values) of the monovalent interaction of E. coli core oligosaccharides with WN1 222-5 by surface plasmon resonance and isothermal titration microcalorimetry. Affinity constants (KD values) determined by SPR were in the range of 3.6 x 10-5 to 3.2 x 10-8 m, with the highest affinity being observed for the core oligosaccharide from E. coli F576 (R2 core type) and the lowest KD values for those from E. coli J-5. Affinities of E. coli R1, R3, and R4 oligosaccharides were 5-10-fold lower, and values from the E. coli J-5 mutant were 29-fold lower than the R2 core oligosaccharide. Thus, the outer core sugars had a positive effect on binding.</Abstract>
            <ArticleYear>2003</ArticleYear>
            <ArticlePages>25618-27</ArticlePages>
            <ArticleTitle>Identification of a cross-reactive epitope widely present in lipopolysaccharide from enterobacteria and recognized by the cross-protective monoclonal antibody WN1 222-5.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Muller-Loennies</LastName>
                    <ForeName>Sven</ForeName>
                </Author>
                <Author>
                    <LastName>Brade</LastName>
                    <ForeName>Lore</ForeName>
                </Author>
                <Author>
                    <LastName>MacKenzie</LastName>
                    <ForeName>C Roger</ForeName>
                </Author>
                <Author>
                    <LastName>Di Padova</LastName>
                    <ForeName>Franco E</ForeName>
                </Author>
                <Author>
                    <LastName>Brade</LastName>
                    <ForeName>Helmut</ForeName>
                </Author>
            </Authors>
            <Affiliations>Research Center Borstel, Center for Medicine and Biosciences, Parkallee 22, D-23845 Borstel, Germany. sml@fz-borstel.de</Affiliations>
            <ArticleChemicalList>Antibodies, Monoclonal;Epitopes;Heptoses;Lipopolysaccharides;Oligosaccharides</ArticleChemicalList>
            <ArticleMeshHeadingsList>Antibodies, Monoclonal(chemistry); Calorimetry; Carbohydrate Sequence; Dose-Response Relationship, Immunologic; Enterobacteriaceae(metabolism); Enzyme-Linked Immunosorbent Assay; Epitopes; Escherichia coli(metabolism); Heptoses(chemistry); Kinetics; Lipopolysaccharides(chemistry); Magnetic Resonance Spectroscopy; Molecular Sequence Data; Mutation; Oligosaccharides(chemistry); Protein Binding; Salmonella enterica(metabolism); Surface Plasmon Resonance; Time Factors</ArticleMeshHeadingsList>
            <Journal>
                <Volume>278</Volume>
                <Issue>28</Issue>
                <Title>The Journal of biological chemistry</Title>
                <Issn>1083-351X</Issn>
                <MedlineTa>J Biol Chem</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Salmonella enterica / Escherichia Coli core trisaccharide</EpitopeName>
                <EpitopeStructure>
                    <FragmentOfANaturalNonSequenceMolecule>
                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                        <Molecule>
                            <ChEBIId>CHEBI:59257</ChEBIId>
                        </Molecule>
                        <SourceMolecule>
                            <ChEBIId>CHEBI:16412</ChEBIId>
                        </SourceMolecule>
                        <SourceOrganismId>543</SourceOrganismId>
                    </FragmentOfANaturalNonSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Abstract</LocationOfData>
                <EpitopeId>133751</EpitopeId>
                <EpitopeEvidenceCode>Exact match to reference information</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Partial Epitope</EpitopeStructureDefines>
                <EpitopeComments>The epitope is defined at the junction of outer and inner core of LPS from enterobacteria, such as E. coli, S. enterica, and Shigella. Additional regions, such as lipid A backbone, the side chain Kdo, or both, are needed for the binding, but the lipids are not involved in the recognition.</EpitopeComments>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1737044</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>262</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>140000.0</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide of E. coli F576 R2 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59309</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1197131</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1737046</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>263</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.048</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide OS1 of E. coli 2513 R4 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59318</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001464</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1737047</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>262</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>87000.0</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide OS1 of E. coli F653 R3 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59316</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001462</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1737048</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>262</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>160000.0</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide OS1 of E. coli 2513 R4 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59318</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001464</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>1737041</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific mAb WN1 222-5 bound to LPS from several E. coli strains tested, such as F470, F576, F653 and 2513, which differ in their core composition but all express the epitope as part of it. The most important contributions to the binding to the antibody come from the side chain heptose and the phosphate at the 4-position of the branched heptose.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Glycolipid</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>562</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1737043</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>263</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.0046</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide of E. coli F576 R2 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59309</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1197131</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>1736010</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific mAb WN1 222-5 bound to the BSA-neoglycoconjugates of S. enterica sv. Minnessota LPS core region to the same extent as to LPS. The most important contributions to the binding to the antibody come from the side chain heptose and the phosphate at the 4-position of the branched heptose.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59320</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>70803</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                            <AntigenContainingObject>
                                <ComplexedMolecule>
                                    <ComplexType>Protein conjugate</ComplexType>
                                    <PeptideModifications/>
                                    <SourceMolecule>
                                        <GenBankId>P02769.4</GenBankId>
                                    </SourceMolecule>
                                    <MoleculeSourceOrganismId>9913</MoleculeSourceOrganismId>
                                </ComplexedMolecule>
                            </AntigenContainingObject>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1736022</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>262</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>160000.0</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide OS1 of E. coli F470 R1 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59284</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001461</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table II</LocationOfData>
                        <BCellId>1736023</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>263</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.028</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide OS1 of E. coli F470 R1 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59284</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001461</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6</LocationOfData>
                        <BCellId>1736011</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>34</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific mAb WN1 222-5 bound to S. enterica sv. Minnessota LPS.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <AccessionNonSequenceMolecule>
                                        <ChemicalType>Glycolipid</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </Molecule>
                                        <SourceOrganismId>70803</SourceOrganismId>
                                    </AccessionNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6, Tables II and III</LocationOfData>
                        <BCellId>1737045</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>263</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>0.031</QuantitativeMeasurement>
                            <AssayComments>The kinetic constants of the free oligosaccharide OS1 of E. coli F653 R3 type LPS core region for binding to the epitope-specific mAb WN1 222-5 was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59316</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001462</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6, Table II</LocationOfData>
                        <BCellId>1736020</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>45</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>330.0</QuantitativeMeasurement>
                            <AssayComments>The epitope-specific mAb WN1 222-5 bound to the BSA-neoglycoconjugates of E. coli 2513 R4 type LPS core region to the same extent as to the complete LPS. The free oligosaccharide affinity to the mAB was tested in SPR and microcalorimetry. The KD values obtained were 330 (at 300 mM NaCl) and 74 (at 150 mM NaCl) nM, respectively.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59318</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001464</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6, Table II</LocationOfData>
                        <BCellId>1736017</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>45</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>700.0</QuantitativeMeasurement>
                            <AssayComments>The epitope-specific mAb WN1 222-5 bound to the BSA-neoglycoconjugates of E. coli F470 R1 type LPS core region to the same extent as to the complete LPS. The free oligosaccharide OS1 (the species shown here) affinity to the mAb was determined by SPR.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59284</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001461</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6, Table II, text.</LocationOfData>
                        <BCellId>1736018</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>45</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>32.0</QuantitativeMeasurement>
                            <AssayComments>The epitope-specific mAb WN1 222-5 bound to the BSA-neoglycoconjugates of E. coli F576 R2 type LPS core region to the same extent as to the complete LPS. The free oligosaccharide was able to compete the binding of the mAb to solid phase-bound LPS, and its affinity to the mAB was tested in SPR and microcalorimetry. The KD values obtained were 32 (at 300 mM NaCl) and 5.5 (at 150 mM NaCl) nM, respectively.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59309</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>1197131</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 6, Tables II and III</LocationOfData>
                        <BCellId>1736019</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10000639</OrganismId>
                                <Age>22 wk</Age>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Organism</EpitopeRelation>
                                    <Object>
                                        <Organism>
                                            <SubType>Organism</SubType>
                                            <SourceOrganismId>543</SourceOrganismId>
                                        </Organism>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenReferenceName>Heat-killed bacteria mixture</ImmunogenReferenceName>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                                <Route>Intravenous (i.v.)</Route>
                                <DoseSchedule>10&lt;sup&gt;8&lt;/sup&gt; CFU bacteria per dose. 4 immunization 1 wk apart, with mixtures of E.coli strains F470, F2513, O18rf, F576, F563 and S.minnesota strain R60.</DoseSchedule>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization details were extracted from a previous reference, Di Padova et al, Infect Immun. 1993 61(9):3863 [PMID 8359907]. The immunogen was a mixture of several enterobacteria: E.coli (F576, F653, F470, F2513, and O18rf ) and S. minnesota R60.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>45</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>380.0</QuantitativeMeasurement>
                            <AssayComments>The epitope-specific mAb WN1 222-5 bound to the BSA-neoglycoconjugates of E. coli F653 R3 type LPS core region to the same extent as to the complete LPS. The free oligosaccharide OS1 (the species shown here) was able to compete the binding of the mAb to solid phase-bound LPS, and its affinity to the mAB was tested in SPR and microcalorimetry. The KD values obtained were 380 (at 300 mM NaCl) and 56 (at 150 mM NaCl) nM, respectively.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Entire Antibody</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>WN1 222-5</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG2a</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenConformation>Non-Native/Unknown</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Taxonomic Child</EpitopeRelation>
                                <Object>
                                    <FragmentOfANaturalNonSequenceMolecule>
                                        <ChemicalType>Carbohydrate fragment</ChemicalType>
                                        <Molecule>
                                            <ChEBIId>CHEBI:59316</ChEBIId>
                                        </Molecule>
                                        <SourceMolecule>
                                            <ChEBIId>CHEBI:16412</ChEBIId>
                                        </SourceMolecule>
                                        <SourceOrganismId>10001462</SourceOrganismId>
                                    </FragmentOfANaturalNonSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Exact match to reference information</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

